Press Release Details

View all news

Bruker Daltonics Announces Schering-Plough's Selection of the New solariX FTMS for Structure Characterization and Impurity Testing

May 29, 2009

BILLERICA, Mass.--(BUSINESS WIRE)--May. 29, 2009-- Bruker Daltonics announced today that the Rapid Structure Characterization Laboratory (RSCL) of the Schering-Plough Research Institute (SPRI) has selected the new solariX™ FTMS platform from Bruker Daltonics as a cutting-edge tool for structural characterization and purity assessment of pharmaceuticals under development at SPRI. The solariX, with its expansive capabilities, is ideally suited as the ultimate analysis platform to address the rigorous challenges of these application areas in pharmaceutical development.

Bruker Daltonics explained that the RSCL can be tasked with solving some of the most difficult chemical structure problems encountered during drug development, as well as many day-to-day applications, that companies have for structural characterization of chemical compounds.

Dr. Gary Martin, Distinguished Fellow at Schering Plough and the leader of the RSCL, commented: “The chemical formula provided by the solariX platform for both the complete unknown, as well as pieces of the unknown compound from MSn, is pivotal information that can complement the information derived from NMR spectroscopy. Combining these data can speed the solving of complex structural problems. We look forward to using solariX in our work.”

Dr. Paul Speir, Vice President for FTMS at Bruker Daltonics, stated: “Our solariX FTMS platform offers unmatched mass resolution and flexibility, a wide variety of ionization techniques, the capability to perform MSn experiments with accurate mass measurement at each stage, and is even capable of ion-molecule reactions. All of these capabilities can be useful in solving the extremely difficult structural characterization problems that pharmaceutical scientists routinely encounter.”

For further product information, please visit


For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit and

Photos/Multimedia Gallery Available:

Source: Bruker Daltonics

Bruker Daltonics
Dr. Paul Speir, +1 978-663-3660

Categories: Press Releases
View all news